Reckitt Benckiser Group PLC (OTCMKTS:RBGLY – Get Free Report) crossed below its two hundred day moving average during trading on Monday . The stock has a two hundred day moving average of $14.43 and traded as low as $13.62. Reckitt Benckiser Group shares last traded at $13.70, with a volume of 1,349,067 shares.
Analyst Upgrades and Downgrades
Several equities research analysts have commented on RBGLY shares. Kepler Capital Markets raised shares of Reckitt Benckiser Group from a “hold” rating to a “strong-buy” rating in a research report on Friday, April 17th. Jefferies Financial Group raised shares of Reckitt Benckiser Group from a “hold” rating to a “buy” rating in a research report on Tuesday. Deutsche Bank Aktiengesellschaft reiterated a “hold” rating on shares of Reckitt Benckiser Group in a research note on Tuesday, June 30th. Finally, Zacks Research upgraded shares of Reckitt Benckiser Group from a “strong sell” rating to a “hold” rating in a research note on Monday, June 15th. Two equities research analysts have rated the stock with a Strong Buy rating, three have assigned a Buy rating and three have issued a Hold rating to the company’s stock. Based on data from MarketBeat.com, Reckitt Benckiser Group presently has an average rating of “Moderate Buy”.
Get Our Latest Report on RBGLY
Reckitt Benckiser Group Stock Up 1.9%
Reckitt Benckiser Group Company Profile
Reckitt Benckiser Group plc is a multinational consumer goods company that develops, manufactures and markets health, hygiene and home products. Its portfolio spans over-the-counter medicines and health products, personal and sexual wellness, surface and laundry cleaning, and household care. The company owns a number of well-known global brands across these categories, including Lysol and Dettol in disinfectants and hygiene, Durex in sexual wellness, Nurofen in analgesics, and Finish in dishwashing products.
The firm has its corporate headquarters in the United Kingdom and sells products in markets around the world, serving consumers across North America, Europe, Asia, Latin America, the Middle East and Africa.
Further Reading
- Five stocks we like better than Reckitt Benckiser Group
- Could Truth API Become Trump Media’s First Meaningful Revenue Driver?
- Small Caps Are Crushing the S&P 500—3 Stocks Still Worth Buying
- Moog Is More Than a Missile Maker, and Wall Street Is Noticing
- A Boring Dividend Growth Strategy Becomes a Solid Defensive Play
Receive News & Ratings for Reckitt Benckiser Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Reckitt Benckiser Group and related companies with MarketBeat.com's FREE daily email newsletter.
